The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Blood Cancer Journal
(Mar 2021)
Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma
Paul G. Richardson,
Thierry Facon,
William I. Bensinger,
Xavier Leleu,
Frank Campana,
Sandrine Macé,
Marielle Chiron,
Helgi van de Velde,
Joseph Mikhael
Affiliations
Paul G. Richardson
Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Thierry Facon
Department of Haematology, Lille University Hospital
William I. Bensinger
Myeloma & Transplant Program, Swedish Cancer Institute
Xavier Leleu
Service d’Hématologie et Thérapie Cellulaire, Hôpital de La Milétrie
Frank Campana
Sanofi-Genzyme
Sandrine Macé
Sanofi R&D
Marielle Chiron
Sanofi R&D
Helgi van de Velde
Sanofi-Genzyme
Joseph Mikhael
Translational Genomics Research Institute (TGen), City of Hope Cancer Center
DOI
https://doi.org/10.1038/s41408-021-00438-y
Journal volume & issue
Vol. 11, no. 3
pp. 1 – 5
Abstract
Read online
No abstracts available.
WeChat QR code
Close